About Cerenion
Cerenion is a company based in Oulu (Finland) founded in 2017 by Timo Koskela, Ilkka Juuso, Jukka Kortelainen, and Eero Vayrynen. Cerenion has raised $2.82 million across 3 funding rounds from investors including Icebreaker.vc, Butterfly Ventures and Springvest. Cerenion offers products and services including C-Trend. Cerenion operates in a competitive market with competitors including Ceribell, INBRAIN Neuroelectronics, Mynd Analytics, Inria and BrainScope, among others.
- Headquarter Oulu, Finland
- Founders Timo Koskela, Ilkka Juuso, Jukka Kortelainen, Eero Vayrynen
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cerenion Oy
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.82 M (USD)
in 3 rounds
-
Latest Funding Round
$2.2 M (USD), Seed
Sep 12, 2019
-
Investors
Icebreaker.vc
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cerenion
Cerenion offers a comprehensive portfolio of products and services, including C-Trend.
AI-assisted tool for real-time EEG waveform analysis in healthcare.
People of Cerenion
Unlock access to complete
Funding Insights of Cerenion
Cerenion has successfully raised a total of $2.82M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.2 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cerenion
Cerenion has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Icebreaker.vc, Butterfly Ventures and Springvest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage tech investments are targeted in Finland.
|
Locked | Locked | Locked | |
|
Seed-stage venture capital funding is provided by Butterfly Ventures.
|
Locked | Locked | Locked | |
|
Springvest is recognized as a leading growth investment service in Finland.
|
Locked | Locked | Locked |
Investor details for Cerenion
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cerenion
Investment portfolio details for Cerenion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cerenion
Detailed financials for Cerenion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cerenion Comparisons
Peer comparison for Cerenion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cerenion
Cerenion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, INBRAIN Neuroelectronics, Mynd Analytics, Inria and BrainScope, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portable EEG devices for point-of-care seizure diagnosis are provided.
|
|
| Locked | Locked | Locked |
AI-based neuroelectronic devices for brain disorder detection are developed.
|
|
| Locked | Locked | Locked |
Provider of reference data and analytic tools for clinicians and researchers in psychiatry.
|
|
| Locked | Locked | Locked |
Software for brain-computer interfaces and neurosciences is developed.
|
|
| Locked | Locked | Locked |
Developer of AI-driven EEG platform transforming brain electrical activity into insights
|
|
| Locked | Locked | Locked |
AI-based EEG analysis is provided for healthcare providers.
|
Detailed competitors of Cerenion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cerenion
Complete news archive for Cerenion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cerenion
Cerenion was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Cerenion is headquartered in Oulu, Finland. It is registered at Oulu, North Ostrobothnia, Finland.
Timo Koskela is the current CEO of Cerenion. They have also founded this company.
Cerenion is a funded company, having raised a total of $2.82M across 3 funding rounds to date.
Cerenion was established in 2017 as a spin-off from the University of Oulu in Finland. Technology for measuring brain function in intensive care settings is developed by the company for diagnostic and therapeutic applications. The medical-grade software solution, Cerenion C-Trend, is utilized, integrating standard EEG measurements with machine learning algorithms and artificial intelligence to support clinical decision-making in neurology-focused healthcare. Operations are based in Oulu, Finland.
Cerenion's top competitors include Ceribell, INBRAIN Neuroelectronics and BrainScope.
Cerenion offers C-Trend.
Cerenion has 4 investors. Key investors include Icebreaker.vc, Butterfly Ventures, Springvest, and CapA.